Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Determinants of Paraoxonase 1 Status: Genes, Drugs and Nutrition

Author(s): C. Schrader and G. Rimbach

Volume 18, Issue 36, 2011

Page: [5624 - 5643] Pages: 20

DOI: 10.2174/092986711798347216

Price: $65

Abstract

Paraoxonase 1 (PON1) is an enzyme which is mainly synthesized in the liver. PON1 circulates in the blood bound to HDL and delays or prevents the oxidation of LDL. Single nucleotide polymorphisms significantly determine PON1 status in humans. A high PON1 status may be associated with a reduced cardiovascular disease risk. By using in silico databases we suggest various transcription factors and micro RNA as putative regulators of PON1. Furthermore we predict functional partners of PON1 by using a text mining tool. Beside genetic and life style factors PON1 status may be determined by drugs (e.g., statins, fibrates) and dietary factors. Dietary modulators of PON1 status include fat and fatty acids, antioxidant vitamins (e.g. ascorbic acid, tocopherol), polyphenols and polyphenol-rich foods.

Keywords: Aging, antioxidant, cardiovascular disease, diet, drugs, fibrate, flavonoids, genetic regulation, oxidized LDL, paraoxonase, polymorphism, polyphenols, statin


Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy